| The endoperoxide ascaridol shows strong differential cytotoxicity in nucleotide excision repair-deficient cells. | |
| | |
MedLine Citation:
|
PMID: 22280988 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Targeting synthetic lethality in DNA repair pathways has become a promising anti-cancer strategy. However little is known about such interactions with regard to the nucleotide excision repair (NER) pathway. Therefore, cell lines with a defect in the NER genes ERCC6 or XPC and their normal counterparts were screened with 53 chemically defined phytochemicals isolated from plants used in traditional Chinese medicine for differential cytotoxic effects. The screening revealed 12 drugs that killed NER-deficient cells more efficiently than proficient cells. Five drugs were further analyzed for IC(50) values, effects on cell cycle distribution, and induction of DNA damage. Ascaridol was the most effective compound with a difference of >1000-fold in resistance between normal and NER-deficient cells (IC(50) values for cells with deficiency in ERCC6: 0.15μM, XPC: 0.18μM, and normal cells: >180μM). NER-deficiency combined with ascaridol treatment led to G2/M-phase arrest, an increased percentage of subG1 cells, and a substantially higher DNA damage induction. These results were confirmed in a second set of NER-deficient and -proficient cell lines with isogenic background. Finally, ascaridol was characterized for its ability to generate oxidative DNA damage. The drug led to a dose-dependent increase in intracellular levels of reactive oxygen species at cytotoxic concentrations, but only NER-deficient cells showed a strongly induced amount of 8-oxodG sites. In summary, ascaridol is a cytotoxic and DNA-damaging compound which generates intracellular reactive oxidative intermediates and which selectively affects NER-deficient cells. This could provide a new therapeutic option to treat cancer cells with mutations in NER genes. |
| | |
Authors:
|
Rashda Abbasi; Thomas Efferth; Christine Kuhmann; Till Opatz; Xiaojiang Hao; Odilia Popanda; Peter Schmezer |
Related Documents
:
|
16396498 - Analysis of total n-glycans in cell membrane fractions of cancer cells using a combinat... 12399048 - Movement on the cell surface of the gliding bacterium, mycoplasma mobile, is limited to... 6585788 - Interaction of the 2,6-dimethoxysemiquinone and ascorbyl free radicals with ehrlich asc... 18625848 - Lectin microarrays identify cell-specific and functionally significant cell surface gly... 12048028 - Mouse resident peritoneal macrophages partially control in vitro infection with coxiell... 22899258 - High-resolution analyses of cell fusion dynamics in a biochip. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-1-17 |
Journal Detail:
|
Title: Toxicology and applied pharmacology Volume: - ISSN: 1096-0333 ISO Abbreviation: - Publication Date: 2012 Jan |
Date Detail:
|
Created Date: 2012-1-27 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0416575 Medline TA: Toxicol Appl Pharmacol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2012. Published by Elsevier Inc. |
Affiliation:
|
Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Overview of neurophysiology of movement control.
Next Document: Transient oxidative stress and inflammation after intraperitoneal administration of multiwalled carb...